Objective To analyze the prevalence and the risk factors for sarcopenia and sarcopenic obesity in patients undergoing maintenance hemodialysis (MHD). Methods A total of 107 patients undergoing MHD at the Department of Nephrology, Beijing Friendship Hospital, Capital Medical University from January 2023 to January 2024 were enrolled in this study. Univariate and multivariate regressions were conducted for the analysis of sarcopenia in MHD patients. Based on body fat percentage (≥30% for males and ≥ 40% for females), the patients were divided into sarcopenic obesity group and non-sarcopenic obesity group. Clinical data were compared between patient groups. Results The prevalence of sarcopenia in MHD patients was 33.6%. Compared to non-sarcopenia patients, the sarcopenia patients had older age (t=2.426, P=0.009), lower body mass index (BMI) (t=-3.541, P=0.001), higher prevalence rates of diabetes (χ²=4.466, P=0.035) and coronary artery disease (χ²=4.306, P=0.038), and higher modified quantitative subjective global assessment (MQSGA) scores (Z=-6.192, P＜0.001). Logistic regression showed that hemodialysis with diffusion and filtration (HDF) (OR=0.167, 95% CI:0.041～0.683, P=0.01) and higher BMI (OR=0.234, 95% CI: 0.074～0.736, P=0.013) were the protective factors against sarcopenia, while higher volume load (OR=4.951, 95% CI: 1.030～23.790, P=0.046) and higher MQSGA scores (OR=10.794, 95% CI: 3.060～38.071, P=0.000) were the risk factors for sarcopenia in MHD patients. The prevalence of sarcopenic obesity in MHD patients was 15.9%. Compared to non-sarcopenic obesity patients, the sarcopenia patients had a lower BMI (F=2.433, P=0.007), a higher body fat percentage (F=-5.661, P=0.007), a lower proportion of HDF (χ²=8.758, P=0.003), and a higher neutrophil to lymphocyte ratio (NLR) (F=-1.008, P=0.006). Conclusion The prevalence rates of sarcopenia and sarcopenic obesity are higher in MHD patients. Early identification and effective management of the abnormalities should be conducted for MHD patients with sarcopenia or sarcopenic obesity.
CHEN Ya-Li
,
DIAO Zong-Li
,
DING Ning
. The influencing factors for sarcopenia and sarcopenic obesity in maintenance hemodialysis patients[J]. Chinese Journal of Blood Purification, 2024
, 23(11)
: 823
-827
.
DOI: 10.3969/j.issn.1671-4091.2024.11.005
[1]Hojs N, Fissell WH, Roy S. Ambulatory hemodialysis-technology landscape and potential for Patient-Centered Treatment[J]. Clin J Am Soc Nephrol, 2020,15(1):152-159.
[2]Huang S W，Ku J W，Lin L F，et a1．Body composition influenced by progressive elastic band resistance exercise of sarcopenic obesity elderly women：a pilot randomized controlled trial[J]．Eur J Phys Rehabil Med，2017，53 (4)：556-563．
[3]A Sayer A，Stewart C，Patel H，et al．The deveIopmental origins of sarcopenia：from epidemiological evidence to underlying mechanisims[J] Dev Orig Health Dis，2010，1(3)：150-157．
[4]Moorthi RN, Avin KG. Clinical relevance of sarcopenia in chronic kidney disease[J].?Curr Opin Nephrol Hypertens?2017,26:219.
[5]Beberashvili I, Azar A, Sinuani I, Shapiro G, et al. Geriatric nutritional risk index, muscle function, quality of life and clinical outcome in hemodialysis patients[J].?Clin Nutr?2016, 35:1522–9.
[6]Baumgartner RN. Body composition in healthy aging[J].?Ann N Y Acad Sci.?2000,904:437–448.
[7] Wannamethee SG, Atkins JL. Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity[J].?Proc Nutr Soc.?2015,74:405–412.
[8]Peng TC, Chen WL, Chen YY, et al. Associations between different measurements of sarcopenic obesity and health outcomes among non-frail community-dwelling older adults in Taiwan[J]. Br J Nutr. 2021,126(11):1749-1757.
[9]Atkins JL, Wannamathee SG. Sarcopenic obesity in ageing: cardiovascular outcomes and mortality[J]. Br J Nutr. 2020 ,124(10):1102-1113.
[10]Du Y, Wang X, Xie H, et al. Sex differences in the prevalence and adverse outcomes of sarcopenia and sarcopenic obesity in community dwelling elderly in East China using the AWGS criteria[J].?BMC Endocr Disord.?2019 ,19((1)):109.
[11]Kalantar-Zadeh K, Kleiner M, Dunne E, et al. A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol Dial Transplant. 1999 ,14(7):1732-8.
[12]Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020 ,21(3):300-307.e2.
[13]Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia[J]. Am Med Dir Assoc. 2014 ,15(2):95-101.
[14]Yoowannakul S, Tangvoraphonkchai K, Vongsanim S, et al. Differences in the prevalence of sarcopenia in haemodialysis patients: the effects of gender and ethnicity[J]. Hum Nutr Diet. 2018,31(5):689-696.
[15]Wathanavasin W，Banjongjit A， Avihingsanon Y， et a1. Prevalence of Sarcopenia and Its Impact on Cardiovascular Events and Mortality among Dialysis Patients: A Systematic Review and Meta-Analysis[J]. Nutrients. 2022 ，14(19):4077.
[16]?ztürk ZA, Kul S, Türkbeyler ?H, et al. Is increased neutrophil lymphocyte ratio remarking the inflammation in sarcopenia? [J].Exp Gerontol. 2018 ,110:223-229.
[17]Borges TC, Gomes TL, Pichard C, et al. High neutrophil to lymphocytes ratio is associated with sarcopenia risk in hospitalized cancer patients[J]. Clin Nutr. 2021,40(1):202-206.
[18]Kim H, Suzuki T, Kim M, Kojima N, Yoshida Y, Hirano H, Saito K, Iwasa H, Shimada H, Hosoi E, Yoshida H. Incidence and predictors of sarcopenia onset in community-dwelling elderly Japanese women: 4-year follow-up study. J Am Med Dir Assoc. 2015 Jan;16(1):85.e1-8.
[19]郑智华,张涤华,张辉,郑勋华,马祖等,郝元涛,余学清.透析充分性、微炎症和残存肾功能对血液透析患营养状者态的影响[J].中华肾脏病杂志,2006,22(12):734-737.
[20]Urabe S, Hyodo T, Hosono T,et al. Amino acid losses are lower during pre-dilution on-line HDF than HD of the same Kt/V for urea[J]. Artif Organs. 2020 ,23(4):342-347.
[21]Guo Q，Yi C，Li J，et a1．Prevalence and risk factors of fluid overload in Southern Chinese continuous ambulatory peritoneal dialysis patients[J]．PLeS One，2013，8(1)：l-10.5
[22]Ohashi Y，Saito A，Yamazaki K，et a1．Brain Natriuretic Peptide and Body Fluid Composition in Patients with Chronic Kidney Dis— ease：A Cross·-Sectional Study to Evaluate the Relationship be·· tween Volume Overload and Malnutrition[J]．Cardiorenal Med， 2016，6(4)：337—346．
[23]Kim YL，Biesen WV．Fluid Overload in Peritoneal Dialysis Patients[J]．Semin Nephrol，2017，37(I)：43—53．
[24]SHAO A，CAMPBELL W W，CHEN C Y O，et al．The emerging global phenomenon of sarcopenic obesity：role of functional foods； a conference report［J］．J Funct Foods，2017，33：244-250．
[25]Sharma D, Hawkins M, Abramowitz MK. Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States.?Clin[J]. Am Soc Nephrol.?2014,9(12):2079–2088.?
[26]Malhotra R, Deger SM, Salat H, et al. Sarcopenic Obesity Definitions by Body Composition and Mortality in the Hemodialysis Patients[J].?Ren Nutr.?2017,27(2):84–90.
[27]Tian SL, Zhang K, Xu PC. Increased prevalence of peripheral arterial disease in patients with obese sarcopenia undergoing hemodialysis[J].?Exp Ther Med.?2018,15(6):5148–5152.?
[28]罗楠,李新伦,陈凤锟,玄方,赵长征,刘静民,伦立德.维持性血液透析相关肌肉减少症的患病率及危险因素的横断面调查[J].中国血液净化,2021,20(8):536-539,545.
[29]Huang SW, Ku JW, Lin LF,et a1 .Body composition influenced by progressive elastic band resistance exercise of sarcopenic obesity elderly women: a pilot randomized controlled trial. Eur J Phys Rehabil Med. 2017 ,53(4):556-563.
[30]Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W,et al. Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial.[J] Clin Oncol. 2018 ，36(9):875-883.
